Scientific Consulting & Regulatory Expertise
Introduction
Accelerating drug and vaccine development requires more than great science—it demands strategic planning and regulatory expertise. Our scientific consulting services help you navigate complex challenges in infectious disease, cardiometabolic disorders, and vaccine development. From early-stage design to global regulatory submissions, we provide integrated solutions that reduce risk and speed time-to-market.
Our Services
-
Regulatory strategy and submissions (IND, CTA, NDA) for vaccines, infectious disease, and cardiometabolic therapies
-
Scientific consulting for study design and development planning
-
Gap analysis and compliance audits aligned with FDA, EMA, and ICH guidelines
-
Translational strategy and biomarker guidance for infectious disease and cardiometabolic programs
Why It Matters
Scientific and regulatory consulting ensures your development program is optimised for success. By integrating regulatory strategy with scientific insight, we help reduce delays, avoid costly missteps, and improve the likelihood of approval. Our expertise in vaccines, infectious disease, and cardiometabolic conditions positions us as a trusted partner for complex programs.
Compliance & Expertise
We align all strategies with global regulatory standards, including FDA, EMA, and ICH guidelines. Our team brings deep experience in regulatory submissions, scientific planning, and translational research to support your program from concept to clinic.
Benefits
-
Reduced risk of regulatory delays and non-compliance
-
Expert guidance for complex therapeutic areas including vaccines and infectious disease
-
Integrated scientific and regulatory approach for cardiometabolic programs
-
Accelerated timelines through strategic planning and modelling
Workflow Overview
-
Consultation & Needs Assessment
-
Regulatory Strategy Development
-
Scientific Planning & Translational Guidance
-
Documentation & Submission Support
Research & Articles
From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
Controlled Human Infection Model's (CHIM) in your backpack: how Human Challenge Trials support regulatory approval of travel vaccines
Unravelling the hMPV Surge: From Media Attention to Vaccine Development
No articles found for this topic.
Plan your next Clinical Trial with hVIVO
If you're a potential customer, find out how hVIVO can help you.